BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18716952)

  • 1. Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome.
    Wang Y; Gaudio PA
    Ocul Immunol Inflamm; 2008; 16(4):167-71. PubMed ID: 18716952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pediatric vogt-koyanagi-harada syndrome with infliximab.
    Khalifa YM; Bailony MR; Acharya NR
    Ocul Immunol Inflamm; 2010 Jun; 18(3):218-22. PubMed ID: 20482402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of infliximab therapy in sight-threatening corticosteroid-resistant Vogt-Koyanagi-Harada disease.
    Zmuda M; Tiev KP; Knoeri J; Héron E
    Ocul Immunol Inflamm; 2013 Aug; 21(4):310-6. PubMed ID: 23617262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of infliximab therapy in two patients with refractory Vogt-Koyanagi-Harada disease.
    Niccoli L; Nannini C; Cassarà E; Gini G; Lenzetti I; Cantini F
    Br J Ophthalmol; 2009 Nov; 93(11):1553-4. PubMed ID: 19854741
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease.
    Khalifa Y; Loh AR; Acharya NR
    Ocul Immunol Inflamm; 2009; 17(6):431-3. PubMed ID: 20001265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N; Morisod L; Herbort CP
    Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Read RW; Yu F; Accorinti M; Bodaghi B; Chee SP; Fardeau C; Goto H; Holland GN; Kawashima H; Kojima E; Lehoang P; Lemaitre C; Okada AA; Pivetti-Pezzi P; Secchi A; See RF; Tabbara KF; Usui M; Rao NA
    Am J Ophthalmol; 2006 Jul; 142(1):119-24. PubMed ID: 16815259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vogt-Koyanagi-Harada disease in children.
    Abu El-Asrar AM; Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D
    Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
    Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
    Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
    Paredes I; Ahmed M; Foster CS
    Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
    Lee GE; Lee BW; Rao NA; Fawzi AA
    Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
    Lai TY; Chan RP; Chan CK; Lam DS
    Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroidal folds in acute Vogt-Koyanagi-Harada disease.
    Zhao C; Zhang M; Wen X; Dong F; Han B; Du H
    Ocul Immunol Inflamm; 2009; 17(4):282-8. PubMed ID: 19657984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Vogt-Koyanagi-Harada syndrome in 11-year-old girl].
    Swiech-Zubilewicz A; Wróblewska E; Mańkowska A
    Klin Oczna; 2005; 107(7-9):511-4. PubMed ID: 16417010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
    Zhang M; Liu Q; Min H; Du H; Hu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):200-3. PubMed ID: 12133385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
    Tabbara KF; Al-Hemidan AI
    Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
    Tsujikawa A; Yamashiro K; Yamamoto K; Nonaka A; Fujihara M; Kurimoto Y
    Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vogt-Koyanagi-Harada syndrome. Epidemiological, clinical and disease progression aspects. Twenty cases].
    Boutimzine N; Laghmari A; Ouazzani I; Ibrahimy W; Mohcine Z
    J Fr Ophtalmol; 1998 Dec; 21(10):746-54. PubMed ID: 10052048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA; Sanchis ME; Fernandez-Munoz M
    J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada disease in Thai patients.
    Tesavibul N; Sansanayuth W
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S26-30. PubMed ID: 16681048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.